Oral and Poster Abstracts
Poster
AML, apoptosis, HSCs, Animal models, Diseases, cell regulation, red blood cells, Biological Processes, DNA damage, white blood cells, immune cells, Technology and Procedures, Cell Lineage, epigenetics, Study Population, Myeloid Malignancies, hematopoiesis, inflammation, integrative -omics, NGS, microenvironment, molecular interactions, pathways, proteomics, signal transduction
Anna Luiza Facchetti Vinhaes Assumpcao, PhD1,2*, Guoping Fu, Ph.D.3*, Zhanping Lu, PhD2*, Ashley Kuehnl1*, Renren Wen, PhD4 and Xuan Pan, PhD, DVM2,5
1Department of Medical Sciences, University of Wisconsin-Madison, Madison, WI
2Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI
3Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI
4BloodCenter of Wisconsin, part of Versiti, Milwaukee, WI
5Carbone Cancer Center, UW-Madison Blood Research Program, University of Wisconsin, Madison, WI
Chengfang Zhou1*, Mei Kuang1*, Jieping Chen2* and Yu Hou, PhD3
1Southwest Hospital, Third Military Medical University (Army Medical University), ChongQing, China
2Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China
3Department of Hematology, Southwest Hospital, Third Military Medical University (Army Medical University), CHONGQING, China
Chao Zhang1*, Zihan Xu1*, Shangda Yang, MD2*, Guohuan Sun3*, Wei Tao1*, Cheng Li, PhD1*, Hui Cheng4* and Tao Cheng5
1Peking University, Beijing, China
2Institute of Hematology & Blood Diseases Hospital, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China
3Institute of Hematology, Tianjin, CHN
4State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
5State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China
Ayame Ogawa1*, Ryo Yamagishi2*, Takeru Matsumoto3*, Satoshi Ansai4,5*, Kiyoshi Naruse5* and Takashi Kato, DSc2,3
1Integrative Bioscience and Biomedical Engineering, Waseda University, Tokyo, TKY, Japan
2Integrative Bioscience and Biomedical Engineering, Waseda University, Tokyo, Japan
3Department of Biology, School of Education, Waseda University, Tokyo, Japan
4Graduate School of Life Sciences, Tohoku University, Sendai, Japan
5National Institute for Basic Biology, Okazaki, Japan
Ding-Wen Chen, PhD1, Seul Jung, BS1*, Jian-Meng Fan, BS1*, Siqi Linsey Zhang1*, Theresa N Menna, BS1*, Zhe Zhang, PhD2*, Sherif Abdelhamed, PhD3 and Peter Kurre, MD1
1Comprehensive Bone Marrow Failure Center, Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
2Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA
3St. Jude Children's Research Hospital, Memphis, TN
*signifies non-member of ASH
denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.